Occult HBV infection in hemodialysis setting is marked by presence of isolated antibodies to HBcAg and HCV

Journal of Nephrology

Volumn 22, Issue 3, 2009, Pages 381-386

  Di Stefano, Mariantonietta ^a   Volpe, Anna ^b   Stallone, Giovanni ^a   Tartaglia, Luciano ^a   Prato, Rosa ^a   Martinelli, Domenico ^a   Pastore, Giuseppe ^b   Gesualdo, Loreto ^a   Fiore, Josè Ramòn ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Anti HCV; Hemodialysis; Isolated anti HBcAg; Occult HBV infection

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA; HEPATITIS C ANTIBODY;

AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; FEMALE; HEMODIALYSIS PATIENT; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; TREATMENT DURATION; ADULT; BLOOD; IMMUNOLOGY; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ADULT; AGED; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 69449083376     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Huang CC. Hepatitis in patients with end-stage renal disease. J Gastroenterol Hepatol. 1997;12:236-241.
2. Zacks SL, Fried MW. Hepatitis B and C renal failure. Infect Dis Clin North Am. 2001;15:877-899.
3. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely "occult"? Hepatology. 2001;34:194-203.
4. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis. 2002;2:479-486.
5. Allain JP. Occult hepatitis B virus infection: implications in transfusion. Vox Sang. 2004;86:83-91.
6. Raimondo G, Pollicino T, Cacciola I, Squadrito G. Occult hepatitis B virus infection. J Hepatol. 2007;46:160-170.
7. Cacciola I, Pollicino T, Squadrito G, Cerenzi G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med. 1999;341:22-26.
8. Fabris P, Brown D, Tositti G, et al. Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C. J Clin Virol. 2004;29:160-166.
9. Kazemi-Shirazi L, Petermann D, Muller C. Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C. J Hepatol. 2000;33:785-790.
10. Lo Re V 3rd, Frank I, Gross R, et al. Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients. J Acquir Immune Defic Syndr. 2007;44:315-320.
11. Hofer M, Joller-Jemeka HI, Grob PJ, Luthy R, Opravil M. Frequent chronic hepatitis B virus infection in HIV-infected patients positive for antibody to hepatitis B core antigen only. Swiss HIV cohort study. Eur J Clin Microbiol Infect Dis. 1998;17:6-13.
12. Manzini P, Girotto M, Borsotti R, et al. Italian blood donors with anti-HBc and occult hepatitis B virus infection. Hematologica. 2007;92:1664-1670.
13. Fabrizi F, Messa PG, Lunghi G, et al. Occult hepatitis B virus infection in dialysis patients: a multicentre survey. Aliment Pharmacol Ther. 2005;21:1341-1347.
14. Joller-Jemelka HI, Wicki AN, Grob PJ. Detection of HBs antigen in "anti-HBc alone" positive sera. J Hepatol. 1994;21:269-272.
15. Thiers V, Nakajima E, Kremsdorf D, et al. Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet. 1988;2:1273-1276.
16. Larsen J, Hetland G, Skaug K. Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier. Transfusion. 1990;30:431-432.
17. Baginski I, Chemin I, Hantz O, et al. Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis. Transfusion. 1992;32:215-220.
18. Regan FA, Hewitt P, Barbara JA, Contreras M. Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood. TTI Study Group. BMJ. 2000;320:403-406.
19. Wachs ME, Amend WJ, Ascher NL, et al. The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation. 1995;59:230-234.
20. Uemoto S, Sugiyama K, Marusawa H, et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation. 1998;65:494-499.
21. De Feo TM, Poli F, Mozzi F, Moretti MP, Scalamogna M; Collaborative Kidney, Liver and Heart North Italy Transplant Program Study Groups. Risk of transmission of hepatitis B virus from anti-HBC positive cadaveric organ donors: a collaborative study. Transplant Proc. 2005;37:1238-1239.
22. Kanbay M, Gur G, Akcay A, et al. Is hepatitis C virus positivity a contributing factor to occult Hepatitis B Virus infection in hemodialysis patients? Dig Dis Sci. 2006;51:1962-1966.
23. Iwai K, Tashima M, Itoh M, et al. Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period. Bone Marrow Transplant. 2000;25:105-108.
24. De Maria N, Colantoni A, Friedlander L, et al. The impact of previous HBV infection on the course of chronic hepatitis C. Am J Gastroenterol. 2000;95:3529-3536.
25. Fukuda R, Ishimura N, Niigaki M. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance. J Med Virol. 1999;58:201-207.
26. Cabrerizo M, Bartolomé J, De Sequera P, Caramelo C, Carreño V. Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen-negative hemodialysis patients and staff. J Am Soc Nephrol. 1997;8:1443-1447.
27. Besisik F, Karaca C, Akyuz F, et al. Occult HBV infection and YMDD variants in hemodialysis patients Wight chronic HCV infection. J Hepatol., 2003;38:506-510.
28. Minuk GY, Sun DF, Greenberg R, et al. Occult hepatitis B virus infection in a North American adult hemodialysis patient population. Hepatology. 2004;40:1072-1077.
29. Goral V, Ozkul H, Tekes S, Sit D, Kadiroglu AK. Prevalence of occult HBV infection in hemodialysis patients with chronic HCV. World J Gastroenterol. 2006;12:3420-3424.
30. Burdick RA, Bragg-Gresham JL, Woods JD, et al. Pattern of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2003;63:2222-2229.
31. Georgiadou SP, Zachou K, Rigopoulou E, et al. Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseases. J Viral Hepat. 2004;11:358-365.
32. Pereira JS, Gonçales NS, Silva C, et al. HBV vaccination of HCV-infected patients with occult HBV infection and anti-HBc-positive blood donors. Braz J Med Biol Res. 2006;39:525-531.